Acupuncture for Lymphedema Secondary to Breast Cancer Treatment
Status
Conditions
Treatments
Details and patient eligibility
About
This study is being conducted to determine if electro-acupuncture can reduce swelling of the arm due to breast cancer treatment (commonly referred to as 'lymphedema'). Research conducted on animals suggests that such treatment might be used to improve circulation leading to reductions in swelling. Previous research in humans with lymphedema suggests that treatment may be safe to use, although results regarding its efficacy in the reduction of swelling have not yet been established.
This research will use sophisticated, non-invasive assessment methods to determine if a single session of electro-acupuncture treatment can be effective for reducing lymphedema. Results may be used to further develop our understanding of how electro-acupuncture can be used in the management of this condition. Electro-acupuncture may provide a promising complement or alternative to conventional lymphedema treatments such as compression bandaging, massage therapy or surgery.
Full description
Participants will be invited to attend a 30-60 minute screening visit to determine eligibility. This screening visit will be located at a laboratory at McMaster University's Institute of Applied Health Sciences. Eligibility will be determined using health questionnaires and non-invasive physical assessment of the upper limbs. Participants may not be eligible for further participation based on their health status and risks to health and safety.
Participants meeting eligibility criteria will be invited to 1 scheduled appointment (30-60 minutes in duration). The appointment time will be scheduled according to individual symptoms, such that it will coincide with the time of day that lymphedema symptoms are predicted to be at their highest. Upon arrival at the scheduled appointment, participants will be randomized to receive 20 minutes of acupuncture+applied electrical stimulation or no treatment. Participants in both groups will be asked to provide physical assessment data over a period of 30 minutes during the scheduled appointment. Differences between groups in tissue swelling of the affected upper-limb will be determined immediately following treatment, and at 10 minutes following treatment.
Participants will be asked to report any significant changes to their health state for a period of 2 weeks following treatment. A follow-up questionnaire will be made available at 2 weeks following attendance of the scheduled appointment.
Sex
Ages
Volunteers
Inclusion criteria
- >1yr following the conclusion of breast cancer treatment
- Lymphedema of the upper limb: unilateral (one-side)
Exclusion criteria
- History or evidence of hormone-receptor positive cancer
- Previous nodal dissection or radiotherapy to other regions
- Contraindications for acupuncture or electrical stimulation
- Pre-cancer or bi-lateral lymphedema
- Evidence of active cancer
- History of contralateral cancer, radiation or surgery
- Edema of the neck/midline/torso
- Pregnancy
- Allergies to nickel, chromium, or silicon
- Seizures (epilepsy)
- Tremors (shakiness) that may interfere with treatment
- Infections, scarring, open wounds, or broken skin at needle sites
- Infections, open wounds, or broken skin on the upper limbs (electrode & landmark sites)
Trial design
Primary purpose
Allocation
Interventional model
Masking
0 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal